ESQlabs GmbH provides consulting and services for the development and utilization of PBPK and QSP modeling and simulation platforms using open-source software to support decision-making in pharmaceuticals, chemicals, and crop protection.

ESQlabs GmbH

apartis develops client-specific software, specializing in solutions for the medical and pharmaceutical sectors, focusing on data mining, data management, quality control, user interfaces, system integration, workflow management, and pooling.

apartis

ESQlabs GmbH provides consulting and services for the development and utilization of physiologically-based pharmacokinetics (PBPK) and quantitative systems pharmacology (QSP) modeling and simulation platforms using open-source software. The company supports decision-making processes across the entire life cycle of pharmaceutical, chemical, or crop protection products.

Metric
Company Name	ESQlabs GmbH	apartis
Symbol
MSH ID	COM:ESQLABS	COM:APARTIS
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Technology
Industry	Pharmaceuticals	Software Development
Country	DE	DE
Stage
Employee Count		11
Website	esqlabs.com	apartis.com
LinkedIn
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

ESQL

COM:ESQLABS

ESQlabs GmbH

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue